Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

June 16, 2017

Study Completion Date

June 20, 2017

Conditions

Healthy

Interventions

DRUG

dabigatran etexilate

single dose

Trial Locations (1)

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku